Of note, a patient with myxofibrosarcoma who had an ongoing deep and sustained response harbored a mutation in PALB2, which is involved in the recruitment of BRCA2 and RAD51 to DNA breaks in the homologous recombination pathway39. This evidence concerns the gene PALB2 and myxofibrosarcoma.